logo
welcome
Guardian

Guardian

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

Guardian
Summary
Nutrition label

74% Informative

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils.

It is used as a repeat treatment for severe asthma at a low dose, but the trial found a higher dose could be very effective if injected at the time of flare-up.

Treatment for asthma and COPD exacerbations have not changed in 50 years , despite causing 3.8 m deaths worldwide a year combined.

VR Score

81

Informative language

85

Neutral language

49

Article tone

formal

Language

English

Language complexity

56

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links